TNFRSF13C and mantle cell lymphoma: We are also encouraged by the recent positive safety report of BAFF‐R CAR T cells with low and reversible Cytokine release syndrome (CRS) and Immune effector cell‐associated neurotoxicity syndrome (ICANS) in three mantle cell lymphoma patients.54